Our staff add value to public sector effectiveness and the independent assurance of public sector administration and accountability, applying our professional and technical leadership to have a real impact on real issues.
The Shadow Minister for Health and Ageing, Mr Stephen Smith, wrote to the Auditor-General on 11 March 2002 formally requesting an investigation into certain matters in relation to the 'Co-Location of National General Practice Organisations', a message detailed in the Health Portfolio Additional Estimates Statements 2001-02. The Federal President of the Australian Medical Association (AMA) Limited wrote to the Auditor-General on 11 March 2002, requesting a comprehensive audit of funding decisions by the Minister for Health and Ageing. The Australian National Audit Office has undertaken a preliminary examination of relevant papers relating to the 'GP House' matter. The preliminary examination focussed on whether or not due process was followed in making the decision to transfer funds between Outcomes. The preliminary examination also considered the procedures adopted by the Department of Health and Aged Care in developing the funding proposal, the advisory role played by the Department of Finance and Administration and specific advice provided by both departments to their Ministers. The examination further considered the disclosure of the related budget measure.
The 30 per cent Private Health Insurance Rebate is a financial incentive for individuals to purchase health insurance cover. The rebate provides for a reimbursement or discount of 30 per cent of the cost of private health insurance. It is available to all Australians who are eligible for Medicare and have private health insurance. The objective of the audit was to determine the effectiveness of Commonwealth Government agencies administration of the rebate.
This follow-up Audit reviewed the Department of Health and Ageing's implementation of the recommendations of Audit Report No. 36, 1999-2000, Home and Community Care. The objective of the follow-up audit was to assess the extent to which the Department had implemented the nine recommendations of Audit Report No. 36, 1999-2000. The audit examined areas relating to funding, guidance, fees, coordination with other aged and disability care programs, acquittals, accountability and data requirements, and records management.
The purpose of the audit was to examine the efficiency, effectiveness and accountability of the Therapeutic Goods Administration's performance in evaluating and approving prescription drugs for public use. In particular the audit focused on analysing elements of the regulatory process associated with the evaluation of prescription drugs. In this context the audit reviewed the administrative operations performed within the Department's Drug Safety and Evaluation Branch, the Australian Drug Evaluation Committee and the Business and Services Branch of the TGA, rather than any processes preceding or succeeding those activities.